SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

31 hedge funds and large institutions have $56.7M invested in Sinovac Biotech, Ltd in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

56% less capital invested

Capital invested by funds: $127M → $56.7M (-$70.8M)

Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$776K
Puts
$265K
Net Calls
Net Calls Change

Top Buyers

1
+$4.08M
2
+$1.36M
3
+$380K
4
Deutsche Bank
Deutsche Bank
Germany
+$324K
5
Barclays
Barclays
United Kingdom
+$192K

Top Sellers

1
-$4.93M
2
-$3.84M
3
-$699K
4
Millennium Management
Millennium Management
New York
-$409K
5
Citadel Advisors
Citadel Advisors
Florida
-$241K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$9.46K
27
$4K
28
$2K
29
$2K
30
$1K
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
1
2